Skip to main content

FDA Advisory Panel Recommends Second Johnson & Johnson Dose to Adults

Publish date:
Video Rating:
Video Duration:

The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee recommended that adults over the age of 18, who have already received an initial dose of Johnson & Johnson  (JNJ) - Get Johnson & Johnson (JNJ) Report and Janssen’s COVID vaccine, receive a second dose of the vaccine two months after initial inoculation.

Many members of the FDA panel said the Johnson & Johnson vaccine should be considered a two-dose vaccine much like the vaccines offered by Pfizer  (PFE) - Get Pfizer Inc. Report and Moderna  (MRNA) - Get Moderna, Inc. Report.

Johnson & Johnson submitted data showing that a second dose, administered two months after the initial dose, boosted protection against symptomatic infection from 72% to 94%.

If the FDA agrees with the recommendation, it will move to the CDC and director Dr. Rochelle Walensky for final approval. The second doses would be available immediately upon approval.

Related Videos